NovellusDx Tissue Collection Protocol

Fore Biotherapeutics

Status: Completed

Conditions: Patients Eligible for Tumor Biopsy; Patients That Have Been Diagnosed With Colorectal Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01791322

PM 01.1

Details and patient eligibility

About

NovellusDx is developing a diagnostic platform for the personalized cancer therapy based on patient derived tumor tissue. The assay is able to sense activating mutations by monitoring their effect on a chip-based device.

Enrollment: 15 patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients that have been diagnosed positive for colon cancer.
• available treatment follow up during cancer treatment

Exclusion criteria

• None